| BCBS Kansas City Medical Policies | Therapeutic Radiopharmaceuticals for Prostate Cancer | |
| BCBS Kansas City Medical Policies | efgartigimod alfa -Vyvgart™ and Vyvgart Hytrulo (efgartigimod alfa/hyaluronidase-qvfc) | |
| BCBS Kansas City Medical Policies | Betibeglogene autotemcel (Zynteglo®) (Intravenous) | |
| BCBS Kansas City Medical Policies | Percutaneous Electrical Nerve Field Stimulation for Functional Abdominal Pain Disorders | |
| BCBS Kansas City Medical Policies | Nivolumab; Relatlimab-rmbw (Opdualag) injection | |
| BCBS Kansas City Medical Policies | Inclisiran (Leqvio®) | |
| BCBS Kansas City Medical Policies | Gender Affirmation Surgery and Hormone Therapy | |
| BCBS Kansas City Medical Policies | Axillary Reverse Mapping for Breast Cancer-Related Lymphedema | |
| BCBS Kansas City Medical Policies | Elivaldogene autotemcel (Skysona) Suspension for Intravenous Infusion | |
| BCBS Kansas City Medical Policies | Annular Closure Devices (e.g., Barricaid®, Xclose®, Inclose™) | |